Australian Needle and Syringe Program Survey (ANSPS)

Date Commenced:
1995
Project Status
Ongoing
Expected Date of Completion:
Ongoing
Project Supporters

Australian Government Department of Health and Ageing

Currently recruiting
No
image - ANSPS 284x284

About the Project

Rationale

People who inject drugs (PWID) are at risk of HIV transmission and are the key population affected by hepatitis C virus (HCV) infection globally. HIV and hepatitis C prevalence estimates among PWID are essential for planning, implementing and evaluating blood borne virus prevention programs.

Aims

To provide serial point prevalence estimates of HIV and hepatitis C antibody prevalence and monitor sexual and injecting behaviour among PWID in Australia

Design & Method

The ANSPS is conducted annually at more than 50 NSP services over a one to two week period in October each year. The project is conducted in all states and territories and recruits between 2000 – 2500 NSP attendees each year. Participants complete a brief self administered questionnaire and provide a capillary blood sample which is subsequently tested for HIV and hepatitis C antibodies.

Progress/Update

Ongoing

Benefits

Monitoring of blood borne viral infections among PWID to inform targeting of public health resources

Project Members
image - 1343873066 Jenny Iversen Replace
NHMRC Early Career Fellow
Ph +61 (0)2 9385 0900
image - 1340850769 Lm Work Photo
Professor and Program Head and NHMRC Senior Research Fellow
Ph +61 (0)2 9385 0936
image - 1338782033 Sammy Chow
Research Assistant
Ph +61 (0)2 9385 9989
Project Collaborators: External

Australian State and Territory health authorities

The Collaboration of Australian Needle and Syringe Programs

St Vincent's Centre for Applied Medical Research (AMR)

NSW State Reference Laboratory for HIV at St Vincent's Hospital

Association for Prevention and Harm Reduction Programs Australia (ANEX)

Australian Injecting and Illicit Drug Users’ League (AIVL)

Project Contacts

Related Projects